Company Legal Name
Latest Valuation
Founded Year
Headquarter
Irregular operates as a specialized research laboratory focused on simulating cyber threats to test and secure frontier artificial intelligence models. Based in Brooklyn, the company addresses the critical need for robust AI security testing as advanced AI systems become increasingly prevalent across industries. Irregular's unique approach involves creating sophisticated threat simulations that help identify vulnerabilities in cutting-edge AI models before deployment. The company's specialized expertise in both cybersecurity and AI positions it at the intersection of two rapidly growing technology sectors. Irregular continues to focus on developing comprehensive security testing methodologies for next-generation AI systems.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





